Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phytotherapy for benign prostatic hyperplasia.
Wilt TJ, Ishani A, Rutks I, MacDonald R. Wilt TJ, et al. Among authors: rutks i. Public Health Nutr. 2000 Dec;3(4A):459-72. doi: 10.1017/s1368980000000549. Public Health Nutr. 2000. PMID: 11276294
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, MacDonald R, Rutks I, Wilt TJ. Tacklind J, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Cochrane Database Syst Rev. 2009. PMID: 19370565 Free PMC article. Updated. Review.
Finasteride for benign prostatic hyperplasia.
Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ. Tacklind J, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Cochrane Database Syst Rev. 2010. PMID: 20927745 Free PMC article. Review.
WITHDRAWN: Cernilton for benign prostatic hyperplasia.
Wilt TJ, Macdonald R, Ishani A, Rutks I, Stark G. Wilt TJ, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2011 May 11;2011(5):CD001042. doi: 10.1002/14651858.CD001042.pub2. Cochrane Database Syst Rev. 2011. PMID: 21563128 Free PMC article. Review.
WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.
Wilt TJ, Macdonald R, Rutks I. Wilt TJ, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD002081. doi: 10.1002/14651858.CD002081.pub2. Cochrane Database Syst Rev. 2011. PMID: 21901681 Free PMC article. Review.
WITHDRAWN: Terazosin for benign prostatic hyperplasia.
Wilt TJ, Howe RW, Rutks I, Macdonald R. Wilt TJ, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD003851. doi: 10.1002/14651858.CD003851.pub2. Cochrane Database Syst Rev. 2011. PMID: 21901686 Free PMC article. Review.
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Tacklind J, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235581 Free PMC article. Updated. Review.
Terazosin for benign prostatic hyperplasia.
Wilt TJ, Howe RW, Rutks IR, MacDonald R. Wilt TJ, et al. Among authors: rutks ir. Cochrane Database Syst Rev. 2002;(4):CD003851. doi: 10.1002/14651858.CD003851. Cochrane Database Syst Rev. 2002. PMID: 12519611 Updated. Review.
Cernilton for benign prostatic hyperplasia.
Wilt T, Mac Donald R, Ishani A, Rutks I, Stark G. Wilt T, et al. Among authors: rutks i. Cochrane Database Syst Rev. 2000;(2):CD001042. doi: 10.1002/14651858.CD001042. Cochrane Database Syst Rev. 2000. PMID: 10796739 Updated. Review.
76 results